Enhabit Inc.
$ 13.60
0.15%
26 Feb - close price
- Market Cap 688,375,000 USD
- Current Price $ 13.60
- High / Low $ 13.62 / 13.57
- Stock P/E N/A
- Book Value 11.29
- EPS -0.24
- Next Earning Report 2026-03-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.03 %
- ROE -0.02 %
- 52 Week High 13.64
- 52 Week Low 6.47
About
Enhabit, Inc. provides home health and hospice services in the United States.
Analyst Target Price
$13.44
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-05 | 2025-08-07 | 2025-05-06 | 2025-03-04 | 2024-11-06 | 2024-08-06 | 2024-05-08 | 2024-03-06 | 2023-11-07 | 2023-08-09 | 2023-05-09 | 2023-02-14 |
| Reported EPS | 0.17 | 0.1 | 0.1 | 0.04 | 0.03 | 0.07 | 0.07 | 0.06 | 0.03 | 0.04 | 0.09 | 0.32 |
| Estimated EPS | 0.12 | 0.1 | 0.0624 | 0.0549 | 0.04 | 0.05 | 0.04 | 0.03 | 0.06 | 0.14 | 0.15 | 0.23 |
| Surprise | 0.05 | 0 | 0.0376 | -0.0149 | -0.01 | 0.02 | 0.03 | 0.03 | -0.03 | -0.1 | -0.06 | 0.09 |
| Surprise Percentage | 41.6667% | 0% | 60.2564% | -27.1403% | -25% | 40% | 75% | 100% | -50% | -71.4286% | -40% | 39.1304% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-04 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.14 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: EHAB
2026-02-25 15:52:41
Monteverde & Associates PC ("the M&A Class Action Firm") has announced an investigation into Enhabit Inc. (NYSE: EHAB) concerning its proposed sale to Kinderhook Industries, LLC. The firm is examining whether the cash offer of $13.80 per share for Enhabit shareholders is a fair deal. Attorney Juan Monteverde, known for recovering millions for shareholders, encourages concerned investors to contact the firm for a free consultation.
2026-02-25 09:52:18
Enhabit (NYSE:EHAB) is scheduled to release its Q4 2025 earnings after market close on Wednesday, March 4th. Analysts forecast earnings of $0.14 per share and revenue of $270.5590 million. The company's stock has recently seen significant movement due to an agreement to be acquired by Kinderhook Industries for $13.80 per share in an all-cash deal.
2026-02-24 15:52:41
Brodsky & Smith is investigating potential claims against Enhabit, Inc.'s Board of Directors regarding the company's sale to Kinderhook Industries, LLC for $13.80 per share, totaling $1.1 billion. The investigation will assess whether the Board failed to conduct a fair process and ensure the deal consideration provides fair value to shareholders. Shareholders of Enhabit are invited to contact the law office with any questions regarding the legal ramifications.
2026-02-24 15:52:17
Enhabit Inc. is being acquired by private equity firm Kinderhook Industries LLC for $1.1 billion, a deal signaling a growing interest in hospice assets within the private equity sector. The acquisition is expected to provide Enhabit with additional resources and expertise for long-term investments without the short-term pressures of public markets, while not significantly altering day-to-day operations or team structure. This transaction highlights a trend of increasing private equity investment in the hospice space, driven by the value proposition of these services in reducing costs and improving quality of care.
2026-02-24 13:59:04
Six analysts have provided mixed ratings for Enhabit (NYSE: EHAB) over the last three months, with an average 12-month price target of $13.23, representing a 28.45% increase from the previous average. The company shows strong financial performance in net margin, ROE, and ROA, but its revenue growth lags industry peers and it has a high debt-to-equity ratio. The article details recent analyst actions, including rating changes and price target adjustments, and provides an overview of Enhabit's market capitalization, financial health, and services.
2026-02-24 10:53:04
Kinderhook Industries is set to acquire Enhabit, a home health and hospice provider, in an all-cash transaction valued at approximately $1.1 billion. Enhabit shareholders will receive $13.80 per share, a 24% premium to its recent closing price. This deal will take Enhabit private, delisting it from the NYSE, and reflects a broader trend of private equity investment in the home-based care sector.
